Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Response to: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al.

Knitza J, Cavagna L, Schett G, Distler JHW.

Ann Rheum Dis. 2019 Apr 17. pii: annrheumdis-2019-215484. doi: 10.1136/annrheumdis-2019-215484. [Epub ahead of print] No abstract available.

PMID:
30995979
2.

Response to: 'Response to: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al' by Knitza et al.

Tjärnlund A, Lundberg IE.

Ann Rheum Dis. 2019 May 8. pii: annrheumdis-2019-215515. doi: 10.1136/annrheumdis-2019-215515. [Epub ahead of print] No abstract available.

PMID:
31068326
3.

Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria.

Greco M, García de Yébenes MJ, Alarcón I, Brandy-García AM, Rúa-Figueroa Í, Loza E, Carmona L.

Ann Rheum Dis. 2019 Sep;78(9):1291-1292. doi: 10.1136/annrheumdis-2019-215031. Epub 2019 Mar 25. No abstract available.

PMID:
30910990
4.

Diagnosis and classification of idiopathic inflammatory myopathies.

Lundberg IE, Miller FW, Tjärnlund A, Bottai M.

J Intern Med. 2016 Jul;280(1):39-51. doi: 10.1111/joim.12524. Review.

5.

Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.

Suzuki S, Uruha A, Suzuki N, Nishino I.

Autoimmun Rev. 2017 Jul;16(7):693-700. doi: 10.1016/j.autrev.2017.05.003. Epub 2017 May 4. Review.

PMID:
28479486
6.

Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy.

Stenzel W, Preuße C, Allenbach Y, Pehl D, Junckerstorff R, Heppner FL, Nolte K, Aronica E, Kana V, Rushing E, Schneider U, Claeys KG, Benveniste O, Weis J, Goebel HH.

Neurology. 2015 Mar 31;84(13):1346-54. doi: 10.1212/WNL.0000000000001422. Epub 2015 Mar 6.

7.

Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.

Johnson C, Connors GR, Oaks J, Han S, Truong A, Richardson B, Lechtzin N, Mammen AL, Casciola-Rosen L, Christopher-Stine L, Danoff SK.

Respir Med. 2014 Oct;108(10):1542-8. doi: 10.1016/j.rmed.2014.09.003. Epub 2014 Sep 18.

8.

Classification, diagnosis, and management of idiopathic inflammatory myopathies.

Lazarou IN, Guerne PA.

J Rheumatol. 2013 May;40(5):550-64. doi: 10.3899/jrheum.120682. Epub 2013 Mar 15. Review. Erratum in: J Rheumatol. 2013 Jul;40(7):1240.

PMID:
23504386
9.

[Myositis specific autoantibodies as a new diagnostic criterion for idiopathic inflammatory myopathies].

Kowalska-Oledzka E, Stern LZ.

Neurol Neurochir Pol. 2000 Mar-Apr;34(2):339-47. Review. Polish.

PMID:
10962726
10.

Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.

Bauhammer J, Blank N, Max R, Lorenz HM, Wagner U, Krause D, Fiehn C.

J Rheumatol. 2016 Aug;43(8):1566-74. doi: 10.3899/jrheum.150844. Epub 2016 Jun 1.

PMID:
27252419
11.

Antisynthetase syndrome: a review of etiopathogenesis, diagnosis and management.

Mirrakhimov AE.

Curr Med Chem. 2015;22(16):1963-75. Review.

PMID:
25981806
12.

Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.

Sarkar K, Weinberg CR, Oddis CV, Medsger TA Jr, Plotz PH, Reveille JD, Arnett FC, Targoff IN, Genth E, Love LA, Miller FW.

Arthritis Rheum. 2005 Aug;52(8):2433-8.

13.

Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.

Ceribelli A, Isailovic N, De Santis M, Generali E, Fredi M, Cavazzana I, Franceschini F, Cantarini L, Satoh M, Selmi C.

Clin Rheumatol. 2017 Feb;36(2):469-475. doi: 10.1007/s10067-016-3453-0. Epub 2016 Oct 20.

14.

Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies.

Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW, Jarzabek-Chorzelska M, Targoff IN, Blaszczyk-Kostanecka M, Jablonska S.

Arthritis Rheum. 1997 Jul;40(7):1257-66.

PMID:
9214426
15.

[Antisynthetase syndrome].

Gran JT.

Tidsskr Nor Laegeforen. 2002 Sep 30;122(23):2270-2. Norwegian.

16.

[The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].

Szabó K, Nagy-Vincze M, Bodoki L, Hodosi K, Dankó K, Griger Z.

Orv Hetil. 2016 Apr 10;157(15):575-83. doi: 10.1556/650.2016.30400. Hungarian.

PMID:
27039996
17.

Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome.

Legault D, McDermott J, Crous-Tsanaclis AM, Boire G.

J Rheumatol. 2008 Jan;35(1):169-71.

PMID:
18176990
18.

Acquired immune and inflammatory myopathies: pathologic classification.

Pestronk A.

Curr Opin Rheumatol. 2011 Nov;23(6):595-604. doi: 10.1097/BOR.0b013e32834bab42. Review.

PMID:
21934500
19.

Advances in the therapy of idiopathic inflammatory myopathies.

Baer AN.

Curr Opin Rheumatol. 2006 May;18(3):236-41. Review.

PMID:
16582685
20.

A Multidisciplinary Evaluation Helps Identify the Antisynthetase Syndrome in Patients Presenting as Idiopathic Interstitial Pneumonia.

Chartrand S, Swigris JJ, Peykova L, Chung J, Fischer A.

J Rheumatol. 2016 May;43(5):887-92. doi: 10.3899/jrheum.150966. Epub 2016 Mar 1.

PMID:
26932342

Supplemental Content

Support Center